Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

Aldosterone-driven hypertension found with unexpected frequency
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 27, 2020
News

Medicare will offer a $35/month insulin-cost cap in 2021
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 27, 2020
News

Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 26, 2020
News

Leadless pacemaker shown safe in older, sicker patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 19, 2020
News

Polygenic risk score helps target AAA screening
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 14, 2020
News

Many hydroxychloroquine COVID-19 prophylaxis trials lack ECG screening
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 12, 2020
News
Onyx stent meets DAPT performance goal in bleeding-risk patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 11, 2020
News

Silent brain infarcts found in 3% of AFib patients, tied to cognitive decline
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 11, 2020
News
UNTOUCHED: Inappropriate shocks cut by subcutaneous ICD improvements
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 8, 2020
News

Coffee drinking linked with fewer arrhythmias
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 7, 2020
News

FOURIER: Evolocumab follow-up shows no cognitive adverse effects
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 4, 2020
News

Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 4, 2020
News

REPLENISH: Oral estradiol/progesterone slowed bone turnover as it cut VMS
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 29, 2020
News
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 29, 2020
News

FDA reiterates hydroxychloroquine limitations for COVID-19
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 24, 2020